接受或拒绝参加ASPRE试验的原因:对早产子痫前期高危女性的定性研究
本研究为定性横断面研究,采用半结构化访谈和模板分析,访谈了ASPRE试验的14名参与者和13名拒绝者。参与者因高危状态、认为阿司匹林常用、操作安全及可获得额外监测而参加;拒绝者则因孕期用药不适和安慰剂对照而不参加,并受信息满意度及伴侣和信任者看法影响。
要点
- 高危状态似乎促使参与者参加试验,拒绝者则希望减少伤害
- 对孕期用药和安慰剂组的不适是拒绝参加的主要原因
- 对医疗人员所提供信息的满意度及伴侣和信任者的看法影响决策
核心结论
- 孕妇参加或拒绝参加药物试验的动机,可理解为应对其高危状态所带来的威胁的一种尝试。
研究设计与样本
- 定性横断面研究,采用目的抽样访谈ASPRE试验的14名参与者和13名拒绝者,使用半结构化访谈和模板分析。
主要发现
- 参与者似乎因高危状态而受到参加试验的激励。
- 参与者参加试验还受到以下因素影响:认为试验药物阿司匹林常用、操作安全,以及相信自己将在孕期获得额外监测。
- 拒绝者对孕期服药和安慰剂组表示不适,似乎受到减少伤害愿望的驱动。
- 对医疗人员所提供信息的满意度以及伴侣和其他信任者的看法也影响了女性的决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify factors that affected the decision of pregnant women at high risk for pre-eclampsia (PE) in accepting or declining participation in a medicated clinical trial (ASPRE) for the prevention of preterm PE. METHOD: This was a qualitative, cross-sectional study. A purposive sample of 14 participants and 13 decliners of the ASPRE trial were interviewed using semi-structured interviews. Data were analysed using template analysis. RESULTS: For participants, their high-risk status seems to have motivated them to take part in the trial. This was enabled by their perception that the trial drug aspirin was commonly used, the safety of the procedure, and the belief that they will be in receipt of extra monitoring in pregnancy. Decliners expressed discomfort about taking medications in pregnancy, and about the presence of the placebo arm; they seemed to be motivated by desire to reduce harm. Satisfaction with the information provided by the medical professionals was also influential in women's decision making, and so were the views of their partners and other trusted individuals. CONCLUSION: Pregnant women's motivation to take part or to decline participation in a medicated trail can be understood as an attempt to cope with the threat posed by their high-risk status.
引用
- Nikčević AV, Dodd Z, Prior J, et al. Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high risk of preterm pre-eclampsia. Prenat Diagn. 2019. PMID: 31479510. doi:10.1002/pd.5554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。